Manning & Napier Life Sciences Series Fund

Class No Load (EXLSX)
Scorecard
1 / 5 Stars
Lipper
1 1 4 3 1
Zacks Investment Research
4 (Sell)
Standard & Poor's
1 / 5 Stars
TheStreet.com
---

Fund Fees

Updated 12.31.2013

Maximum Sales Fees %
Initial
Deferred

Updated 12.31.2013

Maximum Fees %
Administrative
Management 1.0
Redemption

Updated 12.31.2013

Actual Fees %
12b-1 0.0
Management 1.0
Net Expense Ratio: Annual Report 1.16
Net Expense Ratio: Prospectus 1.17

Updated 03.05.2014

Total Cost Projections
3-Year $372.00
5-Year $644.00
10-Year $1,420.00

Purchase Information

Updated 05.01.2013

Minimum Investments
Initial $2,000.00
Additional
Initial IRA
Additional IRA
Initial AIP $0.00
Additional AIP $25.00